IL131380A0 - The use of a compound for the manufacture of a pharmaceutical preparatin for the treatment or prevention of prostate cancer - Google Patents

The use of a compound for the manufacture of a pharmaceutical preparatin for the treatment or prevention of prostate cancer

Info

Publication number
IL131380A0
IL131380A0 IL13138098A IL13138098A IL131380A0 IL 131380 A0 IL131380 A0 IL 131380A0 IL 13138098 A IL13138098 A IL 13138098A IL 13138098 A IL13138098 A IL 13138098A IL 131380 A0 IL131380 A0 IL 131380A0
Authority
IL
Israel
Prior art keywords
prevention
compound
treatment
prostate cancer
preparatin
Prior art date
Application number
IL13138098A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL131380A0 publication Critical patent/IL131380A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL13138098A 1997-02-26 1998-02-26 The use of a compound for the manufacture of a pharmaceutical preparatin for the treatment or prevention of prostate cancer IL131380A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4233597 1997-02-26
PCT/JP1998/000767 WO1998038207A1 (fr) 1997-02-26 1998-02-26 Compositions de traitement ou de prevention du cancer de la prostate

Publications (1)

Publication Number Publication Date
IL131380A0 true IL131380A0 (en) 2001-01-28

Family

ID=12633151

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13138098A IL131380A0 (en) 1997-02-26 1998-02-26 The use of a compound for the manufacture of a pharmaceutical preparatin for the treatment or prevention of prostate cancer

Country Status (20)

Country Link
EP (1) EP0963998B1 (xx)
KR (1) KR20000075651A (xx)
CN (1) CN1131239C (xx)
AT (1) ATE265854T1 (xx)
AU (1) AU739308B2 (xx)
BR (1) BR9807767A (xx)
CA (1) CA2282836A1 (xx)
DE (1) DE69823650T2 (xx)
DK (1) DK0963998T3 (xx)
ES (1) ES2221703T3 (xx)
HK (1) HK1023576A1 (xx)
HU (1) HUP0001441A3 (xx)
ID (1) ID22762A (xx)
IL (1) IL131380A0 (xx)
NO (1) NO994107L (xx)
NZ (1) NZ337048A (xx)
PL (1) PL335365A1 (xx)
PT (1) PT963998E (xx)
RU (1) RU2196582C2 (xx)
WO (1) WO1998038207A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2218840T3 (es) * 1997-07-29 2004-11-16 Sankyo Company Limited Composicion azasteroide para ael tratamiento de la alopecia, el hirsutismo femenino y la seborrea.
TR200605520T2 (tr) 2004-04-14 2006-12-21 Lee Eun-Joo Saç kaybı ve iyi huylu prostatik hiperplazinin tedavisine yönelik farmasötik bileşim
KR100698400B1 (ko) 2004-04-14 2007-03-23 이은주 탈모증 및 전립선비대증 치료를 위한 약제학적 조성물
EP1726650A1 (en) * 2005-05-27 2006-11-29 Universitätsklinikum Freiburg Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
RU2695348C2 (ru) * 2018-04-26 2019-07-23 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России) Способ лечения больных с наличием метастазов в лимфатических узлах и олигометастазов в костях скелета при раке предстательной железы

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8505862D0 (en) * 1985-03-07 1985-04-11 Erba Farmitalia Steroidic 5alpha-reductase inhibitors
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
JPH06293793A (ja) * 1993-02-10 1994-10-21 Sankyo Co Ltd ステロイド−１７−アミド類の製造法
JPH0873492A (ja) * 1994-06-28 1996-03-19 Sankyo Co Ltd アザステロイド類
JPH0819151A (ja) * 1994-06-30 1996-01-19 Furukawa Electric Co Ltd:The アーマロッド巻付構造
HUP9901870A3 (en) * 1996-02-05 1999-11-29 Sankyo Company Ltd Chuo Ku 5alfa-reductase inhibitory preparation for oral administration, process for producing the same, and use thereof
ES2218840T3 (es) * 1997-07-29 2004-11-16 Sankyo Company Limited Composicion azasteroide para ael tratamiento de la alopecia, el hirsutismo femenino y la seborrea.

Also Published As

Publication number Publication date
HUP0001441A2 (hu) 2000-10-28
WO1998038207A1 (fr) 1998-09-03
KR20000075651A (ko) 2000-12-26
NZ337048A (en) 2000-10-27
EP0963998B1 (en) 2004-05-06
EP0963998A4 (en) 2002-06-12
PL335365A1 (en) 2000-04-25
NO994107D0 (no) 1999-08-25
CA2282836A1 (en) 1998-09-03
EP0963998A1 (en) 1999-12-15
AU739308B2 (en) 2001-10-11
HUP0001441A3 (en) 2001-03-28
ES2221703T3 (es) 2005-01-01
DE69823650T2 (de) 2004-12-09
RU2196582C2 (ru) 2003-01-20
AU6115998A (en) 1998-09-18
DE69823650D1 (de) 2004-06-09
NO994107L (no) 1999-08-25
BR9807767A (pt) 2000-02-22
PT963998E (pt) 2004-07-30
ATE265854T1 (de) 2004-05-15
HK1023576A1 (en) 2000-09-15
DK0963998T3 (da) 2004-08-16
ID22762A (id) 1999-12-09
CN1252805A (zh) 2000-05-10
CN1131239C (zh) 2003-12-17

Similar Documents

Publication Publication Date Title
NZ332762A (en) Isobutylgaba and its derivatives for the treatment of pain
HK1019878A1 (en) Total synthesis of antitumor acylfulvenes.
BG106340A (en) Substituted oxoazaheterocyclyl compounds
IL145633A0 (en) Pharmaceutical compounds
CA2323150A1 (en) New porphyrins and their use
AU1367497A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
DE69529619D1 (en) Pyrimidinylpyrazolderivate
GR3035664T3 (en) Novel terphenyl compounds and medicines containing the same
GR3031114T3 (en) Use of a pregnane derivatives for the treatment of tumours.
IL131380A0 (en) The use of a compound for the manufacture of a pharmaceutical preparatin for the treatment or prevention of prostate cancer
GB9302046D0 (en) Antiumoral compound-v
UA66888C2 (uk) 3-тетрагідропіридин-4-іл індоли, спосіб їх отримання та спосіб лікування психічних розладів
PL338414A1 (en) Drug against alopecia
AU2287499A (en) Azetidinecarboxamide derivatives for treating cns disorders
AU2003215571A1 (en) Hydroxylated indirubin derivatives
WO2000010543A3 (de) Arzneimittel enthaltend platinkomplexverbindungen sowie deren verwendung
AU7649796A (en) Compound gexi
AU2178199A (en) Azetidinecarboxamide derivatives for the treatment of cns disorders
AU2178099A (en) Azetidinecarboxamide derivatives for treating cns disorders
EP0928792A3 (en) Bicyclic(3.1.0)hexanes and related compounds
PL318539A1 (en) Inhibition of biosynthesis
AU6943796A (en) Compounds UCH 15
MX9705379A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis vasodilatadora.
MX9705378A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de la obesidad.